GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (SZSE:300347) » Definitions » Market Cap

Hangzhou Tigermed Consulting Co (SZSE:300347) Market Cap : ¥48,669 Mil (As of Apr. 29, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hangzhou Tigermed Consulting Co's share price for the quarter that ended in Mar. 2024 was ¥0. Hangzhou Tigermed Consulting Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 872 Mil. Therefore, Hangzhou Tigermed Consulting Co's market cap for the quarter that ended in Mar. 2024 was ¥0 Mil.

Hangzhou Tigermed Consulting Co's quarterly market cap declined from Sep. 2023 (¥58,103 Mil) to Dec. 2023 (¥47,957 Mil) and declined from Dec. 2023 (¥47,957 Mil) to Mar. 2024 (¥0 Mil).

Hangzhou Tigermed Consulting Co's annual market cap declined from Dec. 2021 (¥111,498 Mil) to Dec. 2022 (¥91,429 Mil) and declined from Dec. 2022 (¥91,429 Mil) to Dec. 2023 (¥47,957 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hangzhou Tigermed Consulting Co's Enterprise Value for Today is ¥42,991 Mil.


Hangzhou Tigermed Consulting Co Market Cap Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Market Cap Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47,334.52 141,006.18 111,497.58 91,429.41 47,956.82

Hangzhou Tigermed Consulting Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83,499.13 56,305.86 58,103.04 47,956.82 -

Competitive Comparison of Hangzhou Tigermed Consulting Co's Market Cap

For the Diagnostics & Research subindustry, Hangzhou Tigermed Consulting Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Tigermed Consulting Co's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hangzhou Tigermed Consulting Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Hangzhou Tigermed Consulting Co's Market Cap falls into.



Hangzhou Tigermed Consulting Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hangzhou Tigermed Consulting Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥54.97*872.418
=¥47,957

Hangzhou Tigermed Consulting Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥0*872.418
=¥0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co  (SZSE:300347) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Hangzhou Tigermed Consulting Co Market Cap Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co (SZSE:300347) Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co (SZSE:300347) Headlines

No Headlines